{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:05:59Z","timestamp":1789088759941,"version":"build-2803163510"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL116270"],"award-info":[{"award-number":["T32HL116270"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30GM145498"],"award-info":[{"award-number":["P30GM145498"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2110108"],"award-info":[{"award-number":["W81XWH2110108"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2110108"],"award-info":[{"award-number":["W81XWH2110108"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006952","name":"Louisiana Board of Regents","doi-asserted-by":"publisher","award":["091A-24"],"award-info":[{"award-number":["091A-24"]}],"id":[{"id":"10.13039\/100006952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2543698"],"award-info":[{"award-number":["2543698"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eye Ear Nose and Throat Foundation of New Orleans, Louisiana Cancer Research Center, Tulane University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hereditary Hemorrhagic Telangiectasia (HHT) is a rare congenital disease in which fragile vascular malformations (VM) focally develop in multiple organs. There are few treatment options and no cure. HHT patients inherit loss-of-function mutations affecting Alk1-Eng signaling; however, why this manifests as VMs remains poorly understood. Here we have developed a fully human cell-based microphysiological system of perfused vasculature in which inducible shRNA controls endogenous Alk1 in primary endothelial cells (EC). Resulting VMs develop over several days, recapitulate patient VM appearance, and require only a subpopulation of Alk1-deficient EC to trigger lesions. Single-cell transcriptomics suggests microvessel pruning and regression contribute to VM, while loss of PDGFB implicates mural cell recruitment. Finally, pharmacological VEGF\/VEGFR inhibition blocks lesion formation. In summary, we have developed an HHT-on-a-chip model that faithfully reproduces HHT patient lesions and that can be used to better understand HHT disease biology and identify potential new HHT drugs.<\/jats:p>","DOI":"10.1038\/s41467-026-76448-w","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:45:17Z","timestamp":1786621517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A microphysiological system HHT-on-a-chip platform recapitulates patient vascular lesions"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5703-2239","authenticated-orcid":false,"given":"Jennifer S.","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Hatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Andrejecsk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3439-7352","authenticated-orcid":false,"given":"William","family":"Van Trigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damie J.","family":"Juat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K.","family":"Looker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6971-2655","authenticated-orcid":false,"given":"Sophia R.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8378-6616","authenticated-orcid":false,"given":"Abraham P.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3223-830X","authenticated-orcid":false,"given":"Christopher C. W.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"76448_CR1","doi-asserted-by":"publisher","first-page":"e005061","DOI":"10.1161\/CIRCGEN.124.005061","volume":"18","author":"AR Anzell","year":"2025","unstructured":"Anzell, A. R., M White, C., Diergaarde, B., Carlson, J. C. & Roman, B. L. Hereditary hemorrhagic telangiectasia prevalence estimates calculated from GnomAD allele frequencies of predicted pathogenic variants in ENG and ACVRL1. Circ. Genom. Precis. Med. 18, e005061 (2025).","journal-title":"Circ. Genom. Precis. Med."},{"key":"76448_CR2","doi-asserted-by":"publisher","unstructured":"Snodgrass, R. O., Chico, T. J. A. & Arthur, H. M. Hereditary haemorrhagic telangiectasia, an inherited vascular disorder in need of improved evidence-based pharmaceutical interventions. Genes 12, https:\/\/doi.org\/10.3390\/genes12020174 (2021).","DOI":"10.3390\/genes12020174"},{"key":"76448_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","volume":"24","author":"CL Shovlin","year":"2010","unstructured":"Shovlin, C. L. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 24, 203\u2013219 (2010).","journal-title":"Blood Rev."},{"key":"76448_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/194589240501900111","volume":"19","author":"BJ Folz","year":"2005","unstructured":"Folz, B. J., Wollstein, A. C., Lippert, B. M. & Werner, J. A. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis. Am. J. Rhinol. 19, 65\u201370 (2005).","journal-title":"Am. J. Rhinol."},{"key":"76448_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11845-008-0220-5","volume":"178","author":"AP Brady","year":"2009","unstructured":"Brady, A. P., Murphy, M. M. & O\u2019Connor, T. M. Hereditary haemorrhagic telangiectasia: a cause of preventable morbidity and mortality. Ir. J. Med. Sci. 178, 135\u2013146 (2009).","journal-title":"Ir. J. Med. Sci."},{"key":"76448_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.thromres.2017.03.003","volume":"153","author":"S Chaturvedi","year":"2017","unstructured":"Chaturvedi, S., Clancy, M., Schaefer, N., Oluwole, O. & McCrae, K. R. Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: a cross-sectional survey. Thromb. Res. 153, 14\u201318 (2017).","journal-title":"Thromb. Res."},{"key":"76448_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00270-008-9344-2","volume":"32","author":"MF Carette","year":"2009","unstructured":"Carette, M. F. et al. Imaging of hereditary hemorrhagic telangiectasia. Cardiovasc. Interv. Radio. 32, 745\u2013757 (2009).","journal-title":"Cardiovasc. Interv. Radio."},{"key":"76448_CR8","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1038\/sj.emboj.7600386","volume":"23","author":"F Lebrin","year":"2004","unstructured":"Lebrin, F. et al. Endoglin promotes endothelial cell proliferation and TGF-beta\/ALK1 signal transduction. EMBO J. 23, 4018\u20134028 (2004).","journal-title":"EMBO J."},{"key":"76448_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/08998280.2012.11928877","volume":"25","author":"JC Williams","year":"2012","unstructured":"Williams, J. C. et al. Combined juvenile polyposis and hereditary hemorrhagic telangiectasia. Proc. Bayl. Univ. Med Cent. 25, 360\u2013364 (2012).","journal-title":"Proc. Bayl. Univ. Med Cent."},{"key":"76448_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10456-018-9602-0","volume":"21","author":"AM Crist","year":"2018","unstructured":"Crist, A. M., Lee, A. R., Patel, N. R., Westhoff, D. E. & Meadows, S. M. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia. Angiogenesis 21, 363\u2013380 (2018).","journal-title":"Angiogenesis"},{"key":"76448_CR11","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1161\/CIRCULATIONAHA.118.036952","volume":"139","author":"AM Crist","year":"2019","unstructured":"Crist, A. M. et al. Angiopoietin-2 inhibition rescues arteriovenous malformation in a Smad4 hereditary hemorrhagic telangiectasia mouse model. Circulation 139, 2049\u20132063 (2019).","journal-title":"Circulation"},{"key":"76448_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/00062752-199809000-00005","volume":"5","author":"DA Marchuk","year":"1998","unstructured":"Marchuk, D. A. Genetic abnormalities in hereditary hemorrhagic telangiectasia. Curr. Opin. Hematol. 5, 332\u2013338 (1998).","journal-title":"Curr. Opin. Hematol."},{"key":"76448_CR13","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ajhg.2019.09.010","volume":"105","author":"DA Snellings","year":"2019","unstructured":"Snellings, D. A. et al. Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia result in Bi-allelic loss of ENG or ACVRL1. Am. J. Hum. Genet. 105, 894\u2013906 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"76448_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/path.4844","volume":"241","author":"SE Wetzel-Strong","year":"2017","unstructured":"Wetzel-Strong, S. E., Detter, M. R. & Marchuk, D. A. The pathobiology of vascular malformations: insights from human and model organism genetics. J. Pathol. 241, 281\u2013293 (2017).","journal-title":"J. Pathol."},{"key":"76448_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1159\/000337762","volume":"33","author":"EJ Choi","year":"2012","unstructured":"Choi, E. J. et al. Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse. Cerebrovasc. Dis. 33, 540\u2013547 (2012).","journal-title":"Cerebrovasc. Dis."},{"key":"76448_CR16","first-page":"456","volume":"5","author":"E Tillet","year":"2014","unstructured":"Tillet, E. & Bailly, S. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia. Front. Genet. 5, 456 (2014).","journal-title":"Front. Genet."},{"key":"76448_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/CIRCRESAHA.107.165530","volume":"102","author":"L David","year":"2008","unstructured":"David, L. et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ. Res. 102, 914\u2013922 (2008).","journal-title":"Circ. Res."},{"key":"76448_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1242\/jcs.002949","volume":"120","author":"M Scharpfenecker","year":"2007","unstructured":"Scharpfenecker, M. et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J. Cell Sci. 120, 964\u2013972 (2007).","journal-title":"J. Cell Sci."},{"key":"76448_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fgene.2015.00025","volume":"6","author":"S Tual-Chalot","year":"2015","unstructured":"Tual-Chalot, S., Oh, S. P. & Arthur, H. M. Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges. Front. Genet. 6, 25 (2015).","journal-title":"Front. Genet."},{"key":"76448_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10456-014-9436-3","volume":"17","author":"C Han","year":"2014","unstructured":"Han, C. et al. VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2. Angiogenesis 17, 823\u2013830 (2014).","journal-title":"Angiogenesis"},{"key":"76448_CR21","first-page":"3487","volume":"119","author":"SO Park","year":"2009","unstructured":"Park, S. O. et al. Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 119, 3487\u20133496 (2009).","journal-title":"J. Clin. Invest."},{"key":"76448_CR22","doi-asserted-by":"publisher","first-page":"e98646","DOI":"10.1371\/journal.pone.0098646","volume":"9","author":"S Tual-Chalot","year":"2014","unstructured":"Tual-Chalot, S. et al. Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression. PLoS One 9, e98646 (2014).","journal-title":"PLoS One"},{"key":"76448_CR23","first-page":"2593","volume":"143","author":"ER Rochon","year":"2016","unstructured":"Rochon, E. R., Menon, P. G. & Roman, B. L. Alk1 controls arterial endothelial cell migration in lumenized vessels. Development 143, 2593\u20132602 (2016).","journal-title":"Development"},{"key":"76448_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/MOH.0000000000000419","volume":"25","author":"WW Sugden","year":"2018","unstructured":"Sugden, W. W. & Siekmann, A. F. Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia. Curr. Opin. Hematol. 25, 237\u2013244 (2018).","journal-title":"Curr. Opin. Hematol."},{"key":"76448_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ncb3534","volume":"19","author":"Y Jin","year":"2017","unstructured":"Jin, Y. et al. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling. Nat. Cell Biol. 19, 639\u2013652 (2017).","journal-title":"Nat. Cell Biol."},{"key":"76448_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10456-024-09924-w","volume":"27","author":"AR Anzell","year":"2024","unstructured":"Anzell, A. R. et al. Blood flow regulates acvrl1 transcription via ligand-dependent Alk1 activity. Angiogenesis 27, 501\u2013522 (2024).","journal-title":"Angiogenesis"},{"key":"76448_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","volume":"23","author":"DE Ingber","year":"2022","unstructured":"Ingber, D. E. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat. Rev. Genet. 23, 467\u2013491 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"76448_CR28","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1039\/D1LC00530H","volume":"21","author":"ML Ewald","year":"2021","unstructured":"Ewald, M. L., Chen, Y. H., Lee, A. P. & Hughes, C. C. W. The vascular niche in next generation microphysiological systems. Lab Chip 21, 3244\u20133262 (2021).","journal-title":"Lab Chip"},{"key":"76448_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1425618","volume":"15","author":"A Martier","year":"2024","unstructured":"Martier, A., Chen, Z., Schaps, H., Mondrinos, M. J. & Fang, J. S. Capturing physiological hemodynamic flow and mechanosensitive cell signaling in vessel-on-a-chip platforms. Front. Physiol. 15, 1425618 (2024).","journal-title":"Front. Physiol."},{"key":"76448_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1039\/C6LC01422D","volume":"17","author":"DTT Phan","year":"2017","unstructured":"Phan, D. T. T. et al. A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications. Lab Chip 17, 511\u2013520 (2017).","journal-title":"Lab Chip"},{"key":"76448_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep31589","volume":"6","author":"A Sobrino","year":"2016","unstructured":"Sobrino, A. et al. 3D microtumors in vitro supported by perfused vascular networks. Sci. Rep. 6, 31589 (2016).","journal-title":"Sci. Rep."},{"key":"76448_CR32","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1177\/1535370217694100","volume":"242","author":"DT Phan","year":"2017","unstructured":"Phan, D. T. et al. Blood-brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood-central nervous system interface. Exp. Biol. Med. 242, 1669\u20131678 (2017).","journal-title":"Exp. Biol. Med."},{"key":"76448_CR33","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1089\/ten.tec.2012.0430","volume":"19","author":"ML Moya","year":"2013","unstructured":"Moya, M. L., Hsu, Y. H., Lee, A. P., Hughes, C. C. & George, S. C. In vitro perfused human capillary networks. Tissue Eng. Part C. Methods 19, 730\u2013737 (2013).","journal-title":"Tissue Eng. Part C. Methods"},{"key":"76448_CR34","doi-asserted-by":"publisher","unstructured":"Hachey, S. J. et al. A human vascularized microtumor model of patient-derived colorectal cancer recapitulates clinical disease. Transl. Res. https:\/\/doi.org\/10.1016\/j.trsl.2022.11.011 (2022).","DOI":"10.1016\/j.trsl.2022.11.011"},{"key":"76448_CR35","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1039\/D0LC01216E","volume":"21","author":"SJ Hachey","year":"2021","unstructured":"Hachey, S. J. et al. An in vitro vascularized micro-tumor model of human colorectal cancer recapitulates in vivo drug responses. Lab Chip 21, 1333\u20131351 (2021).","journal-title":"Lab Chip"},{"key":"76448_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01760-y","volume":"26","author":"SJ Hachey","year":"2024","unstructured":"Hachey, S. J. et al. Targeting tumor-stromal interactions in triple-negative breast cancer using a human vascularized micro-tumor model. Breast Cancer Res. 26, 5 (2024).","journal-title":"Breast Cancer Res."},{"key":"76448_CR37","doi-asserted-by":"publisher","unstructured":"Bender, R. H. F. et al. A vascularized 3D model of the human pancreatic islet forex vivostudy of immune cell-islet interaction. Biofabrication 16, https:\/\/doi.org\/10.1088\/1758-5090\/ad17d0 (2024).","DOI":"10.1088\/1758-5090\/ad17d0"},{"key":"76448_CR38","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1039\/D0LC01216E","volume":"21","author":"SJ Hachey","year":"2021","unstructured":"Hachey, S. J. et al. An in vitro vascularized micro-tumor model of human colorectal cancer recapitulates in vivo responses to standard-of-care therapy. Lab Chip 21, 1333\u20131351 (2021).","journal-title":"Lab Chip"},{"key":"76448_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.devcel.2012.02.005","volume":"22","author":"B Larrivee","year":"2012","unstructured":"Larrivee, B. et al. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev. Cell 22, 489\u2013500 (2012).","journal-title":"Dev. Cell"},{"key":"76448_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10456-019-09701-0","volume":"23","author":"TL Capasso","year":"2020","unstructured":"Capasso, T. L. et al. BMP10-mediated ALK1 signaling is continuously required for vascular development and maintenance. Angiogenesis 23, 203\u2013220 (2020).","journal-title":"Angiogenesis"},{"key":"76448_CR41","doi-asserted-by":"publisher","unstructured":"Bernabeu, M. O. et al. Computer simulations reveal complex distribution of haemodynamic forces in a mouse retina model of angiogenesis. J. R. Soc. Interface 11, https:\/\/doi.org\/10.1098\/rsif.2014.0543 (2014).","DOI":"10.1098\/rsif.2014.0543"},{"key":"76448_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10707-x","volume":"10","author":"M Malinverno","year":"2019","unstructured":"Malinverno, M. et al. Endothelial cell clonal expansion in the development of cerebral cavernous malformations. Nat. Commun. 10, 2761 (2019).","journal-title":"Nat. Commun."},{"key":"76448_CR43","doi-asserted-by":"publisher","unstructured":"DeBose-Scarlett, E. et al. Arteriovenous malformation from a patient with JP-HHT harbours two second-hit somatic DNA alterations in SMAD4. J. Med. Genet. https:\/\/doi.org\/10.1136\/jmg-2024-110569 (2025).","DOI":"10.1136\/jmg-2024-110569"},{"key":"76448_CR44","doi-asserted-by":"publisher","unstructured":"DeBose-Scarlett, E. & Marchuk, D. A. The role of somatic mutation in hereditary hemorrhagic telangiectasia pathogenesis. J. Clin. Med. 14, https:\/\/doi.org\/10.3390\/jcm14134479 (2025).","DOI":"10.3390\/jcm14134479"},{"key":"76448_CR45","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ajhg.2025.03.007","volume":"112","author":"E DeBose-Scarlett","year":"2025","unstructured":"DeBose-Scarlett, E. et al. Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis. Am. J. Hum. Genet. 112, 963 (2025).","journal-title":"Am. J. Hum. Genet."},{"key":"76448_CR46","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.120.053047","volume":"144","author":"H Park","year":"2021","unstructured":"Park, H. et al. Defective flow-migration coupling causes arteriovenous malformations in hereditary hemorrhagic telangiectasia. Circulation 144, 805\u2013822 (2021).","journal-title":"Circulation"},{"key":"76448_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mvr.2015.04.002","volume":"99","author":"PM Torring","year":"2015","unstructured":"Torring, P. M. et al. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia. Microvasc. Res. 99, 118\u2013126 (2015).","journal-title":"Microvasc. Res."},{"key":"76448_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.devcel.2015.06.004","volume":"34","author":"C Korn","year":"2015","unstructured":"Korn, C. & Augustin, H. G. Mechanisms of vessel pruning and regression. Dev. Cell 34, 5\u201317 (2015).","journal-title":"Dev. Cell"},{"key":"76448_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7576","volume":"6","author":"O Salvucci","year":"2015","unstructured":"Salvucci, O. et al. EphrinB2 controls vessel pruning through STAT1-JNK3 signalling. Nat. Commun. 6, 6576 (2015).","journal-title":"Nat. Commun."},{"key":"76448_CR50","doi-asserted-by":"publisher","first-page":"e1009690","DOI":"10.1371\/journal.pgen.1009690","volume":"17","author":"L Wen","year":"2021","unstructured":"Wen, L. et al. The blood flow-klf6a-tagln2 axis drives vessel pruning in zebrafish by regulating endothelial cell rearrangement and actin cytoskeleton dynamics. PLoS Genet. 17, e1009690 (2021).","journal-title":"PLoS Genet."},{"key":"76448_CR51","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","volume":"106","author":"H Al-Samkari","year":"2021","unstructured":"Al-Samkari, H. et al. An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study. Haematologica 106, 2161\u20132169 (2021).","journal-title":"Haematologica"},{"key":"76448_CR52","doi-asserted-by":"publisher","first-page":"e0188943","DOI":"10.1371\/journal.pone.0188943","volume":"12","author":"A Guilhem","year":"2017","unstructured":"Guilhem, A. et al. Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients. PLoS One 12, e0188943 (2017).","journal-title":"PLoS One"},{"key":"76448_CR53","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3892\/etm.2022.11493","volume":"24","author":"H Sadick","year":"2022","unstructured":"Sadick, H. et al. An in vitro study on the effect of bevacizumab on endothelial cell proliferation and VEGF concentration level in patients with hereditary hemorrhagic telangiectasia. Exp. Ther. Med. 24, 555 (2022).","journal-title":"Exp. Ther. Med."},{"key":"76448_CR54","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1007\/s00405-024-09177-9","volume":"282","author":"AM Taha","year":"2025","unstructured":"Taha, A. M. et al. Efficacy of bevacizumab in hereditary hemorrhagic telangiectasia: a systematic review and network meta-analysis. Eur. Arch. Otorhinolaryngol. 282, 2821\u20132832 (2025).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"76448_CR55","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00277-006-0147-8","volume":"85","author":"D Flieger","year":"2006","unstructured":"Flieger, D., Hainke, S. & Fischbach, W. Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab. Ann. Hematol. 85, 631\u2013632 (2006).","journal-title":"Ann. Hematol."},{"key":"76448_CR56","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/alr.21587","volume":"5","author":"NP Arizmendez","year":"2015","unstructured":"Arizmendez, N. P., Rudmik, L. & Poetker, D. M. Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature. Int. Forum Allergy Rhinol. 5, 1042\u20131047 (2015).","journal-title":"Int. Forum Allergy Rhinol."},{"key":"76448_CR57","doi-asserted-by":"publisher","unstructured":"Faughnan, M. E. et al. Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia. Angiogenesis https:\/\/doi.org\/10.1007\/s10456-018-9646-1 (2018).","DOI":"10.1007\/s10456-018-9646-1"},{"key":"76448_CR58","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jtha.2024.10.014","volume":"23","author":"MD Lewandowska","year":"2025","unstructured":"Lewandowska, M. D., Gordon, S., Betbadal, A. & Shapiro, A. D. Pazopanib in treatment of hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding. J. Thromb. Haemost. 23, 525\u2013530 (2025).","journal-title":"J. Thromb. Haemost."},{"key":"76448_CR59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10456-021-09807-4","volume":"25","author":"JG Parambil","year":"2022","unstructured":"Parambil, J. G. et al. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia. Angiogenesis 25, 87\u201397 (2022).","journal-title":"Angiogenesis"},{"key":"76448_CR60","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMc0901421","volume":"360","author":"P Bose","year":"2009","unstructured":"Bose, P., Holter, J. L. & Selby, G. B. Bevacizumab in hereditary hemorrhagic telangiectasia. N. Engl. J. Med. 360, 2143\u20132144 (2009).","journal-title":"N. Engl. J. Med."},{"key":"76448_CR61","first-page":"C92","volume":"320","author":"SR Moses","year":"2021","unstructured":"Moses, S. R., Adorno, J. J., Palmer, A. F. & Song, J. W. Vessel-on-a-chip models for studying microvascular physiology, transport, and function in vitro. Am. J. Physiol. Cell Physiol. 320, C92\u2013C105 (2021).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"76448_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2021.06.002","volume":"159","author":"CJ Mandrycky","year":"2021","unstructured":"Mandrycky, C. J., Howard, C. C., Rayner, S. G., Shin, Y. J. & Zheng, Y. Organ-on-a-chip systems for vascular biology. J. Mol. Cell Cardiol. 159, 1\u201313 (2021).","journal-title":"J. Mol. Cell Cardiol."},{"key":"76448_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121729","volume":"288","author":"K Soon","year":"2022","unstructured":"Soon, K. et al. A human model of arteriovenous malformation (AVM)-on-a-chip reproduces key disease hallmarks and enables drug testing in perfused human vessel networks. Biomaterials 288, 121729 (2022).","journal-title":"Biomaterials"},{"key":"76448_CR64","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1161\/01.RES.0000095246.40391.3B","volume":"93","author":"T Seki","year":"2003","unstructured":"Seki, T., Yun, J. & Oh, S. P. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ. Res. 93, 682\u2013689 (2003).","journal-title":"Circ. Res."},{"key":"76448_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01742-7","volume":"8","author":"JS Fang","year":"2017","unstructured":"Fang, J. S. et al. Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat. Commun. 8, 2149 (2017).","journal-title":"Nat. Commun."},{"key":"76448_CR66","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1242\/dev.00929","volume":"131","author":"F le Noble","year":"2004","unstructured":"le Noble, F. et al. Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development 131, 361\u2013375 (2004).","journal-title":"Development"},{"key":"76448_CR67","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.122.062952","volume":"149","author":"G Genet","year":"2024","unstructured":"Genet, G. et al. Induced endothelial cell cycle arrest prevents arteriovenous malformations in hereditary hemorrhagic telangiectasia. Circulation 149, 944\u2013962 (2024).","journal-title":"Circulation"},{"key":"76448_CR68","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nm.2131","volume":"16","author":"F Lebrin","year":"2010","unstructured":"Lebrin, F. et al. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat. Med. 16, 420\u2013428 (2010).","journal-title":"Nat. Med."},{"key":"76448_CR69","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00018-015-2099-4","volume":"73","author":"E Rossi","year":"2016","unstructured":"Rossi, E. et al. Endoglin regulates mural cell adhesion in the circulatory system. Cell Mol. Life Sci. 73, 1715\u20131739 (2016).","journal-title":"Cell Mol. Life Sci."},{"key":"76448_CR70","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI8088","volume":"104","author":"A Bourdeau","year":"1999","unstructured":"Bourdeau, A., Dumont, D. J. & Letarte, M. A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 104, 1343\u20131351 (1999).","journal-title":"J. Clin. Invest."},{"key":"76448_CR71","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/1523-1747.ep12555569","volume":"95","author":"IM Braverman","year":"1990","unstructured":"Braverman, I. M., Keh, A. & Jacobson, B. S. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J. Invest. Dermatol. 95, 422\u2013427 (1990).","journal-title":"J. Invest. Dermatol."},{"key":"76448_CR72","doi-asserted-by":"publisher","unstructured":"Crampton, S. P., Davis, J. & Hughes, C. C. Isolation of human umbilical vein endothelial cells (HUVEC). J. Vis. Exp. 183, https:\/\/doi.org\/10.3791\/183 (2007).","DOI":"10.3791\/183"},{"key":"76448_CR73","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1093\/bioinformatics\/btx180","volume":"33","author":"I Arganda-Carreras","year":"2017","unstructured":"Arganda-Carreras, I. et al. Trainable Weka Segmentation: a machine learning tool for microscopy pixel classification. Bioinformatics 33, 2424\u20132426 (2017).","journal-title":"Bioinformatics"},{"key":"76448_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1585003","volume":"13","author":"SJ Hachey","year":"2025","unstructured":"Hachey, S. J. et al. Methods for processing and analyzing images of vascularized micro-organ and tumor systems. Front. Bioeng. Biotechnol. 13, 1585003 (2025).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"76448_CR75","doi-asserted-by":"publisher","first-page":"e27385","DOI":"10.1371\/journal.pone.0027385","volume":"6","author":"E Zudaire","year":"2011","unstructured":"Zudaire, E., Gambardella, L., Kurcz, C. & Vermeren, S. A computational tool for quantitative analysis of vascular networks. PLoS One 6, e27385 (2011).","journal-title":"PLoS One"},{"key":"76448_CR76","unstructured":"Kwiatek, G. DXFLib, https:\/\/www.mathworks.com\/matlabcentral\/fileexchange\/33884-dxflib (2022)."},{"key":"76448_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"76448_CR78","unstructured":"Team, R. RStudio: Integrated Development for R, http:\/\/www.rstudio.com (2020)."},{"key":"76448_CR79","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 e3529 (2021).","journal-title":"Cell"},{"key":"76448_CR80","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors. Cell Syst. 8, 329\u2013337 e324 (2019).","journal-title":"Cell Syst."},{"key":"76448_CR81","doi-asserted-by":"publisher","unstructured":"Zappia, L. & Oshlack, A. Clustering trees: a visualization for evaluating clusterings at multiple resolutions. Gigascience 7, https:\/\/doi.org\/10.1093\/gigascience\/giy083 (2018).","DOI":"10.1093\/gigascience\/giy083"},{"key":"76448_CR82","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"76448_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02238-2","volume":"22","author":"L Zhang","year":"2021","unstructured":"Zhang, L. & Nie, Q. scMC learns biological variation through the alignment of multiple single-cell genomics datasets. Genome Biol. 22, 10 (2021).","journal-title":"Genome Biol."},{"key":"76448_CR84","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u201397 (2016).","journal-title":"Nucleic Acids Res."},{"key":"76448_CR85","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"76448_CR86","unstructured":"Gene Ontology Consortium. The Gene Ontology resource: enriching a GOld mine. Nucleic Acids Res. 49, D325\u2013D334 (2021)."},{"key":"76448_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"76448_CR88","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin, S., Plikus, M. V. & Nie, Q. CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat. Protoc. 20, 180\u2013219 (2025).","journal-title":"Nat. Protoc."},{"key":"76448_CR89","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/aivt.2016.0011","volume":"2","author":"A Gough","year":"2016","unstructured":"Gough, A., Vernetti, L., Bergenthal, L., Shun, T. Y. & Taylor, D. L. The microphysiology systems database for analyzing and modeling compound interactions with human and animal organ models. Appl. Vitr. Toxicol. 2, 103\u2013117 (2016).","journal-title":"Appl. Vitr. Toxicol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76448-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76448-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76448-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:06:44Z","timestamp":1789085204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76448-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76448"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76448-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.C.W.H. and A.P.L. are co-founders of, and have an equity interest in, Aracari Biosciences, Inc., which is commercializing the vascularized microtumor model. All work is presented with full knowledge and approval of the UCI Conflict of Interest Oversight Committee. None of the other authors has any potential conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9719"}}